Celldex Therapeutics
CLDX
CLDX
157 hedge funds and large institutions have $1.38B invested in Celldex Therapeutics in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 50 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
28% less call options, than puts
Call options by funds: $20.4M | Put options by funds: $28.5M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
157
Holding in Top 10
–
Calls
$20.4M
Puts
$28.5M
Top Buyers
| 1 | +$35.8M | |
| 2 | +$34.5M | |
| 3 | +$18.3M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$17.7M |
| 5 |
AC
Apex Capital
Orinda,
California
|
+$9.1M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$20.2M | |
| 3 | -$14.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$9.64M |
| 5 |
Jennison Associates
New York
|
-$8.72M |